Evidence map›Paper›PMID 19501699›Full record

ReviewPediatric clinics of North America2009

Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis.

Joyce M Koenig, William J Keenan

Open access · greenAbstract readHistorical ArticleReview
In one paragraph

Review in Pediatric clinics of North America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Inflammatory markers in cord blood or maternal serum for early detection of neonatal sepsis-a systemic review and meta-analysis.Journal of perinatology : official journal of the California Perinatal Association · 2014
    Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Protective role of IL-18 in host defenses against group B Streptococcus.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Risk factors for group B streptococcal disease in neonates of mothers with negative antenatal testing.Journal of perinatology : official journal of the California Perinatal Association · 2017
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Joyce M KoenigDepartment of Pediatrics, Division of Neonatal-Perinatal Medicine, Saint Louis University, Saint Louis, MO 63104, USA. koenijm@slu.edu
William J Keenan
Saint Louis University · ESSaint Louis University · US

Funding

Neutrophil Apoptosis and Neonatal InflammationR01HD047401 · NICHD · UNIVERSITY OF FLORIDA · PI KOENIG, JOYCE MARIE · 2005 to 2009
$1.5M
NICHD NIH HHS HD047401NICHD NIH HHS R01 HD047401
6 · The paper itself

Abstract

Despite an era of marked success with universal screening, Group B Streptococcus (GBS) continues to be an important cause of early-onset sepsis, and thus remains a significant public health issue. Improved eradication of GBS colonization and disease may involve universal screening in conjunction with rapid diagnostic technologies or other novel approaches. Given the complications and potential limitations associated with maternal intrapartum prophylaxis, however, vaccines may be the most effective means of preventing neonatal GBS disease. The global utility of conjugated GBS vaccines may be hampered by the variability of serotypes in diverse populations and geographic locations. Modern technologies, such as those involving proteomics and genomic sequencing, are likely to hasten the development of a universal vaccine against GBS.

Indexed as

Antibiotic ProphylaxisStreptococcus agalactiaeAge of OnsetBacteremiaContraindicationsDrug Resistance, BacterialFemaleHistory, 19th CenturyHistory, 20th CenturyHumansInfant, NewbornInfant, Newborn, DiseasesInfant, Very Low Birth WeightInfectious Disease Transmission, VerticalNeonatal ScreeningPregnancyStreptococcal VaccinesVirulence Factors

Identifiers

PMID19501699
PMCPMC2702484
OpenAlexW1964900947

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.